SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kerala Ayurveda Ltd (530163)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530163 NSE: Pharmaceuticals & Drugs | Small Cap | Kerala Ayurveda Share Price

₹169.55 -5.20 (-2.98%)

As on 04-Jun'26 16:59

Kerala Ayurveda Ltd (530163)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530163 NSE: Pharmaceuticals & Drugs | Small Cap | Kerala Ayurveda Share Price

₹169.55 -5.20 (-2.98%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹220 Cr.
Current Price
₹169.6
52-Week Low / High
₹150 / 625
TTM EPS
₹-11.3
TTM Sales
₹85.5 Cr.
Book Value per Share
₹28.1
P/E Ratio
0.00
Industry PE
46.5
Price to Book (P/B)
6.04
Lower than its 5-year historical median
Price to Sales (P/S)
2.58
Lower than its 5-year historical median
EV/EBITDA
-56.88
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-47.40%
Underperforms industry median
Return on Capital Employed (ROCE)
-10.61%
Underperforms industry median
Return on Assets (ROA)
-11.60%
Operating Profit Margin
-17.3%
Net Profit Margin
-18.96%
Gross Profit Margin
-14.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-0.62%
Operating Profit Growth (1 Year)
-
-351.3%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
35.61%
Pledged shares (%) of Promoter's holding (%)
20.35%
Reserves
₹23 Cr.
Equity
₹13 Cr.
Face Value
₹10
All Time Low / High
₹1.40 / 625.00

Kerala Ayurveda stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Kerala Ayurveda Ltd a good quality company?
Kerala Ayurveda Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Kerala Ayurveda Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Kerala Ayurveda Ltd vs industry peers?
Kerala Ayurveda Ltd revenue CAGR is 6.25%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Kerala Ayurveda Ltd?
Promoters hold 35.61% of the Kerala Ayurveda Ltd, with 20.35% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Kerala Ayurveda Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 14% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kerala Ayurveda Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 4.6%6%7%5.1%3.7%-0.6%10.2%9.9%5%-10.6%-
Value Creation
Index
-0.7-0.6-0.5-0.6-0.7-1.0-0.3-0.3-0.6-1.8-

Growth Parameters

Sales 32.639.643.846.553.743.255.863.373.172.785
Sales YoY Gr.-21.7%10.5%6.2%15.5%-19.5%29.2%13.4%15.6%-0.6%-
Adj EPS 1.62.12.20.30.8-4.70.80.9-0.2-12.5-11.3
YoY Gr.-27.4%4.3%-86.7%186.2%-665.1%NA2.4%-125.6%NA-
BVPS (₹) 14.914.116.712.8116.77.811.132.615.728.1
Adj Net
Profit
1.72.22.30.30.9-50.90.9-0.3-15.1-15
Cash Flow from Ops. 2.51.5-10.99.34.7-0.98.89.1-4.22.3-
Debt/CF from Ops. 25.933.9-6.4612.3-72.377-14.723.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 9.3%6.3%9.2%-0.6%
Adj EPS -225.4%-272.1%-346.2%NA
BVPS0.6%7.3%26.2%-51.8%
Share Price 11% 24.2% 12.2% -62.9%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
11.714.514.226.2-40.18.47.1-0.9-44.7-51.8
Op. Profit
Mgn %
12.612.112.96.55.80.513.97.56.9-17.3-26.9
Net Profit
Mgn %
5.35.65.30.71.6-11.51.61.4-0.4-20.7-17.3
Debt to
Equity
4.13.53.94.259.47.45.51.62.90.1
Working Cap
Days
543432415421329422320283285315165
Cash Conv.
Cycle
839910510794112797288120-21

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales33404446544356637373
Operating Expenses + 28353843514348596885
Manufacturing Costs55678689118
Material Costs77810111213141618
Employee Cost 11111314161312162036
Other Costs 6111213161215192124
Operating Profit 456330855-13
Operating Profit Margin (%) 12.6%12.1%12.9%6.5%5.8%0.5%13.9%7.5%6.8%-17.3%
Other Income + 0000000005
Exceptional Items 0001000300
Interest 1122166544
Depreciation 1111111112
Profit Before Tax 23321-7120-13
Tax 11110-20-110
Profit After Tax 22211-513-0-14
PAT Margin (%) 5.3%5.6%5.3%2.6%1.6%-11.5%1.6%4.6%-0.4%-19.0%
Adjusted EPS (₹)1.62.12.21.10.8-4.70.82.7-0.2-11.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Kerala Ayurveda - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 16151813151011154219
Share Capital 11111111111111111212
Reserves 54734-114307
Debt +64527056585836636052
Long Term Debt5018394547482949526
Short Term Debt143431111111714846
Minority Interest0000000000
Trade Payables1234655665
Others Liabilities 271014162239141538
Total Liabilities 83761008794969198124114

Fixed Assets

Net Fixed Assets +16171617171728303031
Gross Block25262727282941444448
Accumulated Depreciation9101011111213131417
CWIP 0691012122001
Investments 1111111111111111119
Inventories5910111199101310
Trade Receivables567991010121723
Cash Equivalents 21412102160
Others Assets 43254229313530333638
Total Assets 83761008794969198124114

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 22-1195-199-42
PBT 43342-1774-13
Adjustment 012-61111110
Changes in Working Capital -2-3-17121-111-96
Tax Paid 000-1000000
Cash Flow From Investing Activity + -1-2-2-2-4-21-5-2-6
Capex -0-2-3-2-3-1-2-1-1-7
Net Investments 0-000000000
Others -0-110-1-13-4-10
Cash Flow From Financing Activity + -2116-1102-11-221-12
Net Proceeds from Shares 00000000280
Net Proceeds from Borrowing -0121628-191230
Interest Paid -1-1-2-2-1-6-6-4-4-2
Dividend Paid 0000000000
Others -00-4-15-1-014-9-6-9
Net Cash Flow 0-03-41-1-1215-16

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.6514.4414.167.696.98-53.0211.6429.02-1.07-47.4
ROCE (%)4.615.967.045.063.71-0.6110.199.925.04-10.61
Asset Turnover Ratio0.430.50.50.50.590.460.60.670.660.66
PAT to CFO Conversion(x)11-5.595N/A93N/AN/A
Working Capital Days
Receivable Days49.8052.9055.8062.8060.8079.6065.9064.707293.50
Inventory Days58.1068.2080.3081.3075.5088.6061.8054.9056.9054.60
Payable Days93.7082.80124133.20157.30160.30147.10145.50142.30117.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *7.450.0013.3613.3613.3613.3620.6923.5623.5620.35
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Kerala Ayurveda Ltd FAQs

The current trading price of Kerala Ayurveda on 04-Jun-2026 16:59 is ₹169.6.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Kerala Ayurveda stood at ₹220.3 Cr

The latest P/E ratio of Kerala Ayurveda as of 03-Jun-2026 is 0.00.

The latest P/B ratio of Kerala Ayurveda as of 03-Jun-2026 is 6.04.

The 52-week high of Kerala Ayurveda is ₹625.0 and the 52-week low is ₹150.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kerala Ayurveda is ₹85.48 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kerala Ayurveda Ltd is a below average quality company.

The key valuation ratios of Kerala Ayurveda Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Kerala Ayurveda Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Kerala Ayurveda Ltd

Kerala Ayurveda Ltd. (KAL) was founded on the banks of river Periyar at Aluva, Kochi, Kerala in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen in Ayurvedic system, a visionary and a mentor. Now, more than half a century later, his inspired creation epitomizes all that is modern and state-of-the-art in Ayurveda. A leading Ayurvedic company today, KAL is backed by advanced technology and highly qualified dedicated staff.

Today Kerala Ayurveda is a major force in healthcare, growing at a spectacular rate -- with new clinics, new market strategies, new products, and new cures. Some of KAL's products are on the verge of being patented. KAL is truly on a mission to be the number one choice in Ayurveda globally.

Kerala Ayurveda has its world class manufacturing facility at Aluva, near Kochi. It also has a Herbarium.

The R&D Division of KAL has a prestigious herbal garden, which is actually a gene pool with more than 1200 species of rare and endangered medicinal plants, collected by conducting extensive surveys. These efforts also include certain hitherto unexplored tribal pockets, which are treasure groves of herbal wealth.

KAL has started its own Ayurvedic training center in view of propagating authentic Ayurveda. The training center, called KAL HRD CENTER is functioning as an annex to KAL Ayurveda Hospital at Aluva, near Kochi in Kerala. The center is easily assessable since it is located about 10 km, from the Nedumbassery International Airport (Cochin).The center is well equipped and conducts various training programme, various training Programs related with Ayurveda are offered by KAL HRD Center.

Publication Division- KAL has set up a publication division to publish Ayurvedic materials. An Ayurvedic quarterly journal named and styled as KAL VAIDYAM is published by this division. The division is designed to publish books, audio and video CDs and tapes on Ayurveda for the public and the scientific community.

Different offerings of the company:

  • Classical Medicines- These are formulations manufactured based on the Ayurvedic Formulatory of India. This is developed from 3000 years old scriptures. In KAL they  follow the traditional method for manufacturing these products.
  • Proprietary Medicines- These medicines are manufactured based on the formulas developed by KAL R&D division. The products are clinically tested by clinical trial, animal trial, etc before being launched in the market.
  • Katrasoft- Katrasoft is the technology division of Katra group, a multinational company with diverse business intrests in over 15 domains and investments in over 20 companies. Katrasoft operates as a division of Kerala Ayurveda Limited, one of the oldest names in Ayurveda, which is a listed company owned by Katra group.
  • Katra Nursing- Katra Nursing, one of the divisions of Katra Healtcare Pvt.Ltd. is a fast growing healthcare organization centered in Bangalore, India focussed in the training program of CGFNS, NCLEX and IELTS. The primary objective of the organization is to be a one-stop solution provider for nursing fraternity by exploring the best opportunities availble for KAL's nurses.

Achievements/ recognition:

KAL Hospital, Aluva has been accredited with “Green Leaf” certification by Department of Tourism, Government of Kerala, which is the highest classification for outstanding quality of facilities and services.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×